The Drug Enforcement Administration (DEA) and also the Section of Health and Human Companies (HHS) are committed to ensuring Harmless and ready entry to medications for opioid use disorder (MOUD) and have released a joint letter to all DEA registrants to help guarantee that individuals who need buprenorphine will be able to accessibility it without